← Leaderboards
Mehmet Asim Bilen
University Of Tx Md Anderson Can Ctr
$1,152,987
Attributed
$2,305,974
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $876.1K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,305,974 · 1
By mechanism
R01$2,305,974 · 1
Top collaborators
- Veronika Fedirko4 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Lilie Leming Lin$2,171,805
- Florencia McAllister$3,653,632
- Lanlan Shen$6,924,000
- Marina Y Konopleva$11,210,192
- Simona Shaitelman$1,919,054
Others in their field
Other Rising Stars on “Future”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Mari Ostendorf · University Of Washington$51,931,230
- Jeffrey Leintz · National Opinion Research Center$40,628,545
- Eric M Benway · Woods Hole Oceanographic Institution$32,293,242
- Walt Lee$25,884,232
- Cyrus Wadia · Activate Global, Inc.$24,000,000
Research focus
FutureAdverse EventAftercare16s Ribosomal Rna SequencingBloodBlood SpecimenButyratesCancer CenterBiological MarkersAccountingCancer TherapyComplexDemographicsDesignDiagnosisDietDiet ModificationDisease ProgressionDisease RemissionCancer ImmunotherapyEthnic OriginCancer PatientFreezingGenes
Grant awards (4)
Gut Microbiome and Cancer Immunotherapy Outcomes in Advanced Renal Cell Carcinoma$876,059
R01 · FY2025 · CA
Gut Microbiome and Cancer Immunotherapy Outcomes in Advanced Renal Cell Carcinoma$139,551
R01 · FY2024 · CA
Gut Microbiome and Cancer Immunotherapy Outcomes in Advanced Renal Cell Carcinoma$651,814
R01 · FY2023 · CA
Gut Microbiome and Cancer Immunotherapy Outcomes in Advanced Renal Cell Carcinoma$638,550
R01 · FY2022 · CA